EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI
- 0408.292.992
- BE0408292992
- Avenue Emmanuel Mounier 83, 1200 Woluwe-Saint-Lambert
- See the 5 companies at this address
- 18 June 1963
Profile
Official information from the CBE (FPS Economy).
EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI is a Belgian company (Association internationale sans but lucratif) whose registered office is established at 1200 Woluwe-Saint-Lambert. Its main activity falls under “Recherche-développement en autres sciences physiques et naturelles” (NACE 72109).
- Legal form
- Association internationale sans but lucratif
- Legal situation
- Situation normale
- Date of incorporation
- 18 June 1963
- Main activity (NACE)
- 72109Recherche-développement en autres sciences physiques et naturelles
An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more
Company names
Official names in several languages: legal name, trade name, abbreviation.
- EORTC
Secondary activities
4 additional NACE codes declared.
Your risk analysis on this company
AML Company ran EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI through your due diligence questionnaire. Here are the first findings.
What is the geographic exposure of the client and of its transactions?
Belgium only· Registered office published in the register
What is the company's solvency and lifecycle status?
Trading, no proceedings· Legal situation published in the register
Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.
Run the full analysisThis preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.
Establishments
1 active establishment unit declared with the CBE.
Finances & financial health
Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).
Equity & result
| Financial year | Equity | Result | Turnover / gross margin | Headcount (FTE) |
|---|---|---|---|---|
| 2025 | €90,419,410 | €10,330,543 | €52,290,507turnover | 220,3 |
| 2024 | €80,088,867 | €6,681,719 | €51,347,591turnover | 217,8 |
| 2023 | €73,407,147 | €6,226,885 | €47,175,973turnover | 230,7 |
| 2022 | €67,180,262 | -€4,543,919 | €35,077,819turnover | 235,8 |
Financial ratios
Solvency, liquidity and profitability, computed year by year from the filed annual accounts.
Equity / balance sheet total
Current assets / debts due within one year
Result for the year / turnover
Operating result / turnover
This year's filing does not carry the item the calculation needs.
Debts due after one year / balance sheet total
Result for the year / equity
Balance sheet structure
| Ratio | 2025 | 2024 | 2023 | Trend |
|---|---|---|---|---|
| Solvency | 66,9% 8,7% | 58,2% 1,8% | 56,5% 1,4% | |
| Liquidity | 3,06 x 0,68 | 2,39 x 0,07 | 2,32 x flat | |
| Net margin | 19,8% 6,7% | 13% 0,2% | 13,2% 26,2% | |
| Operating margin | 21,1% 4,2% | 16,9% 2,6% | 14,2% 20,7% | |
| Long-term debt | - | - | - | - |
| Return on equity | 11,4% 3,1% | 8,3% 0,1% | 8,5% 15,2% |
Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.
Filing history (18)▾
| Financial year | Filing | Filing type | Model | Source |
|---|---|---|---|---|
| 01/01/2025 → 31/12/2025 | 29/06/2026 | Initial | m05-f | BNB |
| 01/01/2024 → 31/12/2024 | 01/07/2025 | Initial | m05-f | BNB |
| 01/01/2023 → 31/12/2023 | 01/07/2024 | Initial | m05-f | BNB |
| 01/01/2022 → 31/12/2022 | 28/08/2023 | Initial | m05-f | BNB |
| 01/01/2021 → 31/12/2021 | 23/06/2022 | Initial | m05-f | BNB |
| 01/01/2020 → 31/12/2020 | 29/06/2021 | Initial | m05-f-p | BNB |
| 01/01/2020 → 31/12/2020 | 29/06/2021 | Initial | m05-f-p | BNB |
| 01/01/2019 → 31/12/2019 | 22/09/2020 | Initial | m05-f-p | BNB |
| 01/01/2019 → 31/12/2019 | 22/09/2020 | Initial | m05-f-p | BNB |
| 01/01/2018 → 31/12/2018 | 02/08/2019 | Initial | m05-f-p | BNB |
| 01/01/2018 → 31/12/2018 | 28/06/2019 | Initial | m05-f-p | BNB |
| 01/01/2017 → 31/12/2017 | 27/06/2018 | Initial | m05-f-p | - |
Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.
The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.
Notices in the Belgian Official Gazette
Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.
- DEMISSIONS, NOMINATIONS5 February 2026
- DEMISSIONS, NOMINATIONS8 October 2025
- DIVERS30 September 2024
- DEMISSIONS, NOMINATIONS26 August 2024
Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.
What the EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI record does not say
Two readings of the register the raw data does not give: anti-money-laundering scope, and whether the filing deadline was met.
Is EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI subject to anti-money-laundering obligations in Belgium?
Did EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI file its annual accounts on time?
Company timeline
Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.
10 AI-analysed dimensions are not shown.
- 2026
- 29 June 2026Annual accounts filed·Financial year ended 31 December 2025 · Model m05-fFiled accounts2026-00211031
- 2025
- 1 July 2025Annual accounts filed·Financial year ended 31 December 2024 · Model m05-fFiled accounts2025-00205515
- 2024
- 1 July 2024Annual accounts filed·Financial year ended 31 December 2023 · Model m05-fFiled accounts2024-00185831
- 2023
- 28 August 2023Annual accounts filed·Financial year ended 31 December 2022 · Model m05-fFiled accounts2023-00357987
- 2022
- 23 June 2022Annual accounts filed·Financial year ended 31 December 2021 · Model m05-fFiled accounts2022-20084767
Registry record since 7 September 2026
The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.
AI extraction of strategic AML data
The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.
- Legal life
- Restructuring
- Capital
- Legal form
- Incorporation
- Directors
- Beneficial owners
- Registered office
- Company name
- Notarial deeds
Similar companies
Same business sector and geographic area.
Belgian Society of Pediatric Heamatology-Oncology
European Forum for Research and Education in Allergy and Airway Diseases
CROPLIFE INTERNATIONAL
EDANA
Airlines International Representation in Europe
INDUSTRIAL MINERALS ASSOCIATION EUROPE
SOCIETE INTERNATIONALE DE LA SCIENCE HORTICOLE - I.S.H.S. - INTERNATIONAL SOCIETY FOR HORTICULTURAL SCIENCE
SAB Diagnostics
CELLTEST
Step it up
Full analysis unlocked.
Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.